Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation

Fundamental and Clinical Pharmacology

Volumn 12, Issue 5, 1998, Pages 553-558

  Lucas, D ^a   Farez, C ^b   Bardou, L G ^a   Vaisse, J ^b   Attali, J R ^b   Valensi, P ^b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

Chlorzoxazone; Cytochrome P450 2E1; Diabetes; Obesity

Indexed keywords

3 HYDROXYBUTYRIC ACID; ANESTHETIC AGENT; BIGUANIDE; CHLORZOXAZONE; CHOLESTEROL; CYTOCHROME P450 2E1; CYTOCHROME P450 ISOENZYME; ENFLURANE; FRUCTOSAMINE; GLYCOSYLATED HEMOGLOBIN; INSULIN; KETONE; PARACETAMOL; PHENAZONE; SEVOFLURANE; SULFONYLUREA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG DETOXIFICATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROXYLATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032437172     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00985.x     Document Type: Article

References (40)

1. Barnett CR, Flatt PR, Ioannides C. Role of ketone bodies in the diabetes-induced changes in hepatic mixed-function oxidase activities. Bioch Biophys Acta 1988 ; 967 : 250-4
2. Barnett CR, Abbott RA, Bailey CJ, Flatt PR, Ioannides C. Cytochrome-dependent mixed-function oxidase and glutathion S-transferase activities in spontaneous obesity-diabetes. Biochem Pharmacol 1992 ; 43 : 1868-71
3. Barnett C, Flatt PR, Ioannides C. Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocininduced insulin-dependent diabetes. J Biochem Toxicol 1994 ; 9 : 63-9
4. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991 ; 40 : 405-12
5. Bellward GD, Chang T, Rodrigues B, McNeill JH, Maines S, Ryan DE, Levin W, Thomas PE. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat. Mol Pharmacol 1988 ; 33 : 140-3
6. Blouin RA, Kolpek JH, Mann HJ. Influence of obesity on drug disposition. Clin Pharm 1987 ; 6 : 706-14
7. Carriere V, Berthou F, Baird S, Belloc C, Beaune P, De Waziers I. Human cytochrome P4502E1 : from genotype to genotype. Pharmacogenetics 1996 ; 6 : 203-11
8. Chen TL, Chen SH, Tai TY, Chao CC, Park SS, Guengerich FP, Ueng TH. Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters. Arch Toxicol 1996 ; 70 : 202-8
9. De Waziers I, Garlatti M, Bouguet J, Beaune PH, Barouki R. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line. Mol Pharmacol 1995 ; 47 : 474-9
10. Dong Z, Hong J, Ma Q, Li D, Bullock J, Gonzales F, Park SS, Gelboin HV, Yang CS. Mechanism of induction of cytochrome P-450ac (P450j) in chemically induced and spontaneously diabetic rats. Arch Biochem Biophys 1988 ; 263 : 29-35
11. Ekström G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450. Biochem Pharmacol 1989 ; 38 : 1313-8
12. Girre C, Lucas D, Hispard E, Ménez C, Dally S, Ménez J-F. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 1994 ; 47 : 1503-8
13. Goldstein S, Simpson A, Saenger P. Hepatic drug metabolism is increased in poorly controlled insulin-dependent diabetes mellitus. Acta Endocrinol 1990 ; 123 : 550-6
14. Gonzales FJ, Gelboin HV. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 1994 ; 26 : 165-83
15. Higuchi H, Sato H, Arimura S. Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia. Anesth Analg 1993 ; 77 : 1018-21
16. Higuchi H, Sumikura H, Sumita S. Renal function in patients with high fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 1995 ; 83 : 449-58
17. Johansson I, Ekström G, Schölte B, Puzycki D, Jörnvall H, Ingelman-Sundberg M. Ethanol-, fasting-, and acetone-inducible cytochromes P-450 in rat liver: Regulation and characteristics of enzymes belonging to the II B and II E gene subfamilies. Biochemistry 1988 ; 27 : 1925-34
18. Karash ED. Biotransformation of sevoflurane. Anesth Analg 1995 ; 81 : S27-38
19. Kim RB, O'Shea D, Wilkinson GR. Interindividual variability in chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphism. Clin Pharmacol Ther 1995 ; 57 : 645-55
20. Koop DR, Coon MJ. Ethanol oxidation and toxicity: role of alcohol P-450 oxygenase. Alcoholism Clin Exp Res 1986 ; 10 : S44-9
21. Leclerq I, Horsmans Y, Dasager JP, Pauwels S, Geubel AP. Influence of diet on liver volume and cytochrome P 450 (CYP) activities in human non-alcoholic fatty liver (Abstract). Hepatology 1996 ; 24 : 311A
22. Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997 ; 77 : 517-44
23. Lucas D, Berthou F, Girre C, Poitrenaud F, Ménez J-F. High-Performance Liquid Chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum and urine: a tool for indirect evaluation of cytochrome P450 2E1 activity in humans. J Chromatogr Biomed Appl 1993 ; 622 : 79-86
24. Lucas D, Ménez C, Girre C, Bodénez P, Hispard E, Ménez J-F. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcoholism Clin Exp Res 1995 ; 19 : 362-6
25. Lucas D, Ménez C, Girre C, Berthou F, Bodénez P, Joannet I, Hispard E, Bardou LG, Ménez J-F. Cytochrome P4502E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 1995 ; 5 : 298-304
26. Lucas D, Berthou F, Ménez J-F. Chlorzoxazone: In vitro and in vivo substrate probe for liver CYP2E1. Meth Enzymol 1996 ; 272 : 115-23
27. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Eastbrook R, Gunsalus IC, Neben, P. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996 ; 6 : 1-42
28. O'Shea D, Davis SN, Kim RB, Wilkinson GR. Effect of fasting and obesity in humans on the 6-hydoxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 1994 ; 56 : 359-67
29. Peter R, Bolker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450 IIE1. Chem Res Toxicol 1990 ; 3 : 566-73
30. Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB. Induction of cytochrome P450IIE1 in the obese overfed rat. Mol Pharmacol 1990 ; 39 : 275-80
31. Shimojo N. Cytochrome P450 changes in rats with streptozotocin-induced diabetes, Int J Biochem 1994 ; 26 : 1261-8
32. Song BJ, Matsunaga T, Hardwick JP, Park SS, Veech RL, Yang CS, Gelboin HV, Gonzales FJ. Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol Endocrinol 1987 ; 1 : 542-7
33. Song BF, Veech RL, Saenger P. Cytochrome P450 IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J Clin Endocrinol Metab 1990 ; 71 : 1036-40
34. Song BJ. Gene structure and mutiple regulations of the ethanol-inducible cytochrome P4502E1 (CYP2E1) subfamily. In: Watson R, Ed. Drug and Alcohol Abuse Reviews, Vol 6: Alcohol and Hormones. Towota, NJ: Humana press Inc; 1995. p 177-92
35. Sotaniemi EA, Arranto AJ, Salmele PI, Stengard JH, Pelkonen RO. Hepatic microsomal enzyme activity in patients with non-insulin dependent diabetes mellitus (NIDDM and its clinical significance. Acta Endocrinol 1984 ; 262 (suppl) : 125-9
36. Warren BL, Pak R, Finlayson M, Gontovnicle L, Sunahara G, Bellward GD. Differential effects of diabetes on microsomal metabolism of various substrates. Biochem Pharmacol 1983 ; 32 : 327-35
37. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddie C. Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis. Hepatology 1998 ; 27 : 128-33
38. Yoo JSH, Ning SM, Pantuck CB, Pantuck EJ, Yang CS. Regulation of hepatic microsomal cytochrome P450IIE1 level by dietary lipids and carbohydrates in rats. J Nutr 1991 ; 121 : 959-61
39. Yun YP, Casazza JP, Sohn DH, Veech RL, Song BJ. Pretranslational activation of cytochrome P450IIE during ketosis induced by high fat diet. Mol Pharmacol 1992 ; 41 : 474-9
40. Zangar RC, Novack RF. Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes. Arch Biochem Biophys 1997 ; 337 : 217-4